INT MEDICAL (01501) announced its annual performance with a net profit of 2.33 billion yuan, an increase of 22.43% year-on-year.

INT MEDICAL (01501) announced its annual performance as of December 31, 2025, with revenue of 1.065 billion yuan, a year-on-year increase of 25.06%; gross profit of 637 million yuan, a year-on-year increase of 18.44%; net profit of 233 million yuan, a year-on-year increase of 22.43%; and earnings per share of 1.26 yuan. It plans to distribute a dividend of 0.23 yuan per share. The announcement stated that the increase in revenue was due to an increase in the number of new customers and business consolidation. The group generated approximately 968 million yuan in revenue from the sale of medical devices during the reporting period, an increase of about 25.17% from approximately 773 million yuan in the previous fiscal year ending December 31, 2024.